Recent developments in the field of vascular liver diseases

被引：3
|
作者：
Valla, Dominique C. [1 ,2 ]
机构：
[1] Univ Paris, Hop Beaujon, AP HP, Serv Hepatol, 100 Blvd Leclerc, Clichy La Garenne 92118, France
[2] INSERM, 100 Blvd Leclerc, Clichy La Garenne 92118, France
来源：
LIVER INTERNATIONAL | 2020年 / 40卷
关键词：
anticoagulants; cirrhosis; congenital extrahepatic portsystemic shunt; direct oral anticoagulants; non-specific beta blockers; portal flow velocity; portal hypertension; portal vein thrombosis; PORTAL-VEIN THROMBOSIS; INTRAHEPATIC PORTOSYSTEMIC SHUNT; NONSELECTIVE BETA-BLOCKERS; ORAL ANTICOAGULANTS; VENOUS THROMBOSIS; CIRRHOSIS; RISK; MANAGEMENT; EFFICACY; IMPACT;
D O I：
10.1111/liv.14348
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Knowledge in the field of vascular liver disease is continuously expanding. The present update will discuss recent data on i) the Abernethy malformation in adults; ii) portal vein thrombosis in cirrhosis; iii) advancing expertise in recanalization of the portal vein and iv) experience in using direct oral anticoagulants in the field of vascular liver disease.
引用
收藏
页码：142 / 148
页数：7
相关论文
共 50 条
12345